GlycoMimetics Inc
NASDAQ:GLYC

Watchlist Manager
GlycoMimetics Inc Logo
GlycoMimetics Inc
NASDAQ:GLYC
Watchlist
Price: 0.157 USD -99.05%
Market Cap: 10.1m USD

Operating Margin
GlycoMimetics Inc

0%
Current
-140 645.8%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.5m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

GlycoMimetics Inc
Glance View

Market Cap
10.1m USD
Industry
Biotechnology

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company is headquartered in Rockville, Maryland and currently employs 52 full-time employees. The company went IPO on 2014-01-10. The company is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer, and infection. Its drug candidates include Uproleselan, GMI-1359, GMI-1687, and Galectin Antagonists. The company is developing Uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia (AML). Its GMI-1359 targets both E-selectin and a chemokine receptor known as CXCR4. The company has designed an antagonist of E-selectin, GMI-1687, that is suitable for subcutaneous administration. The company has designed various small-molecule glycomimetic antagonists of galectin-3, including a product candidate that has demonstrated oral bioavailability.

GLYC Intrinsic Value
0.166 USD
Undervaluation 5%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.5m
/
Revenue
0
What is the Operating Margin of GlycoMimetics Inc?

Based on GlycoMimetics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top